Theravance Biopharma (TBPH) Peer Comparison

$17.03

$0.00 (0.00%)

As on 25-Sep-2026 09:30EDT

Market cap

$884 Mln

Revenue (TTM)

$104 Mln

P/E Ratio

16.4

P/B Ratio

3.1

Div. Yield

0 %

Edit

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Market cap ($ Mln)	884	1
Revenue ($ Mln)	104	1
Net Profit ($ Mln)	53.81	-5.68
Net Margin (%)	51.58	-591.67
RoE (%)	18.35	-49.04
Price to Earnings	16.38	--
Price-To-Book	3.05	0.28

Cashflow
Ratios

Cashflow ($ Mln)

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Cash From Operating Activities	238.54	-1.84
Cash Flow from Investing Activities	-105.28	--
Cash from Financing Activities	-3.25	4.41
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
ROCE (%)	35.44	-5.34
ROE (%)	18.35	-49.04
ROA (%)	10.97	-59.31
EBIT Margin (%)	61.61	0.00
Net Margin (%)	51.58	-591.67
Cash Profit Margin (%)	0.00	--

Growth Ratios

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Revenue Growth (%)	35.11	--
EBIT Growth (%)	50.13	--
Net Profit Growth (%)	312.92	68.06
EPS Growth (%)	331.49	0.98
Book Value Growth (%)	26.50	--

Valuation Ratios

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Price / Earnings	9.37	-5.72
Price / Book Value	3.35	0.34
Dividend Yield (%)	--	--
EV/EBITDA	5.49	-4.28
Market Cap ($ Cr)	--	--

Solvency Ratios

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.04	74.65
Current Ratio	13.54	0.45
Quick Ratio	13.54	0.45
Interest Coverage	51.97	-35.64

Operating Efficiency Ratios

	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR
Debtors to sales (%)	19.54	0.00
Asset Turnover	0.21	0.10
Receivable days	278.67	--
Inventory Days	-4,537.51	--
Payable days	159.28	--
Cash Conversion Cycle	-4,418.12	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly